Back to Browse Journals » Vascular Health and Risk Management » Volume 3 » Issue 6

Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease

Authors Mohammed Al-Omran

Published Date January 2007 Volume 2007:3(6) Pages 1019—1027


Published 15 January 2007

Mohammed Al-Omran

Department of Surgery, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia

Background: Peripheral arterial disease (PAD) is a marker of advanced atherosclerosis with an elevated risk of cardiovascular mortality and morbidity. Although intensive risk reduction therapy is critical in reducing the adverse cardiovascular outcomes in patients with PAD, the awareness of this information among all physicians is felt to be low. Given the role of family physicians (FP), general internists (GI), cardiologists (C), and vascular surgeons (VS) in treating patients with PAD, we sought to determine their perceptions and knowledge of risk reduction therapy in these patients.

Methods and results: We conducted a cross-sectional self-administered survey of 84 physicians who work at a major teaching hospital. FP, GI, C, and VS represent 39%, 33%, 16%, and 12% of the surveyed physicians, respectively. The recommended targets of LDL-cholesterol, blood glucose and blood pressure in PAD patients were known to 37.3%, 94.1% and 35.3% of physicians, respectively. The majority of physicians reported to screen for risk factors in PAD. Although 86.3% of physicians would recommend antiplatelets therapy in PAD, only 17.6% would recommend angiotensin converting enzyme (ACE) inhibitors; 25.5% would recommend nicotine replacement therapy for smokers and 62.7% would recommend statins. Compared to other specialties, cardiologists had the lowest threshold, whereas GI had the highest threshold for initiating antiplatelets and statins for patients with PAD.

Conclusion: The perceptions towards risk reduction in PAD identify glaring knowledge and action gaps. Effective strategies to encourage health professionals to use risk reduction therapy are needed.
Keywords: peripheral arterial disease, risk reduction, atherosclerosis

Download Article [PDF] 

Readers of this article also read:

Nutritional self-care in two older Norwegian males: a case study

Tomstad ST, Söderhamn U, Espnes GA, Söderhamn O

Clinical Interventions in Aging 2013, 8:609-620

Published Date: 31 May 2013

Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension

Shimizu Y, Yamasaki F, Furuno T, Kubo T, Sato T, Doi Y, Sugiura T

International Journal of General Medicine 2012, 5:753-758

Published Date: 10 September 2012

Lysine-functionalized nanodiamonds: synthesis, physiochemical characterization, and nucleic acid binding studies

Kaur R, Chitanda JM, Michel D, Maley J, Borondics F, Yang P, Verrall RE, Badea I

International Journal of Nanomedicine 2012, 7:3851-3866

Published Date: 19 July 2012

Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac

Guadalupe Cervantes-Coste, Yuriana G Sánchez-Castro, Mónica Orozco-Carroll, Erick Mendoza-Schuster, Cecilio Velasco-Barona

Clinical Ophthalmology 2009, 3:219-226

Published Date: 26 February 2009

Effect of short-term lycopene supplementation and postprandial dyslipidemia on plasma antioxidants and biomarkers of endothelial health in young, healthy individuals

Steven G Denniss, Thomas D Haffner, Jeffrey T Kroetsch, Sara R Davidson, James WE Rush, Richard L Hughson

Vascular Health and Risk Management 2008, 4:213-222

Published Date: 6 March 2008

Phacoviscocanalostomy for open-angle glaucoma with concomitant age-related cataract

Alexandros N Stangos, Anestis Mavropoulos, Gordana Sunaric-Megevand

Clinical Ophthalmology 2007, 1:497-504

Published Date: 11 January 2007